These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 20513304)
1. The effectiveness of harm reduction in preventing HIV among injecting drug users. Wodak A; Maher L N S W Public Health Bull; 2010; 21(3-4):69-73. PubMed ID: 20513304 [TBL] [Abstract][Full Text] [Related]
2. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Wodak A; Cooney A Subst Use Misuse; 2006; 41(6-7):777-813. PubMed ID: 16809167 [TBL] [Abstract][Full Text] [Related]
3. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users]. Takács IG; Demetrovics Z Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245 [TBL] [Abstract][Full Text] [Related]
4. Estimating the cost-effectiveness of needle-syringe programs in Australia. Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579 [TBL] [Abstract][Full Text] [Related]
5. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed. Emmanuel F; Fatima M Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206 [TBL] [Abstract][Full Text] [Related]
6. HIV and injecting drug use in Indonesia: epidemiology and national response. Afriandi I; Aditama TY; Mustikawati D; Oktavia M; Alisjahbana B; Riono P Acta Med Indones; 2009 Jul; 41 Suppl 1():75-8. PubMed ID: 19920303 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055 [TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of harm reduction. Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China]. Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241 [TBL] [Abstract][Full Text] [Related]
10. The role of needle exchange programs in HIV prevention. Vlahov D; Junge B Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812 [TBL] [Abstract][Full Text] [Related]
11. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen. Maher L; Iversen J; Kaldor J Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184 [No Abstract] [Full Text] [Related]
12. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M; Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278 [TBL] [Abstract][Full Text] [Related]
13. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Emmanuelli J; Desenclos JC Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629 [TBL] [Abstract][Full Text] [Related]
14. Malaysia and harm reduction: the challenges and responses. Reid G; Kamarulzaman A; Sran SK Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356 [TBL] [Abstract][Full Text] [Related]
15. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519 [TBL] [Abstract][Full Text] [Related]
16. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users. Amundsen EJ Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880 [No Abstract] [Full Text] [Related]
17. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731 [TBL] [Abstract][Full Text] [Related]
18. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs). Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288 [TBL] [Abstract][Full Text] [Related]
19. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia. Panda S; Sharma M Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181 [TBL] [Abstract][Full Text] [Related]
20. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Ritter A; Cameron J Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]